Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debora Soncini

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Leukemia|August 21, 2019
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myelomaElisa Taiana, Vanessa Favasuli, Domenica Ronchetti, et al.
Blood Advances|September 11, 2020
Amino acid depletion triggered by ʟ-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell deathDebora Soncini, Paola Minetto, Claudia Martinuzzi, et al.
The Journal of Biological Chemistry|October 22, 2014
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activityDebora Soncini, Irene Caffa, Gabriele Zoppoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2015
APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia CellsAntonia Cagnetta, Irene Caffa, Chirag Acharya, et al.
Haematologica|October 14, 2017
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agentsAntonia Cagnetta, Debora Soncini, Stefania Orecchioni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2016
Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation StatusMichele Cea, Antonia Cagnetta, Chirag Acharya, et al.
Plos One|August 6, 2011
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cellsMichele Cea, Debora Soncini, Floriana Fruscione, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD<sup>+</sup>-Lowering AgentsPamela Becherini, Debora Soncini, Silvia Ravera, et al.
Haematologica|October 15, 2020
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programsDebora Soncini, Stefania Orecchioni, Samantha Ruberti, et al.
Haematologica|October 21, 2021
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatmentDebora Soncini, Claudia Martinuzzi, Pamela Becherini, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Leukemia|August 21, 2019
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myelomaElisa Taiana, Vanessa Favasuli, Domenica Ronchetti, et al.
Blood Advances|September 11, 2020
Amino acid depletion triggered by ʟ-asparaginase sensitizes MM cells to carfilzomib by inducing mitochondria ROS-mediated cell deathDebora Soncini, Paola Minetto, Claudia Martinuzzi, et al.
The Journal of Biological Chemistry|October 22, 2014
Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activityDebora Soncini, Irene Caffa, Gabriele Zoppoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2015
APO866 Increases Antitumor Activity of Cyclosporin-A by Inducing Mitochondrial and Endoplasmic Reticulum Stress in Leukemia CellsAntonia Cagnetta, Irene Caffa, Chirag Acharya, et al.
Haematologica|October 14, 2017
Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agentsAntonia Cagnetta, Debora Soncini, Stefania Orecchioni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2016
Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation StatusMichele Cea, Antonia Cagnetta, Chirag Acharya, et al.
Plos One|August 6, 2011
Synergistic interactions between HDAC and sirtuin inhibitors in human leukemia cellsMichele Cea, Debora Soncini, Floriana Fruscione, et al.
Antioxidants (Basel, Switzerland)|February 25, 2023
CD38-Induced Metabolic Dysfunction Primes Multiple Myeloma Cells for NAD<sup>+</sup>-Lowering AgentsPamela Becherini, Debora Soncini, Silvia Ravera, et al.
Haematologica|October 15, 2020
The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programsDebora Soncini, Stefania Orecchioni, Samantha Ruberti, et al.
Haematologica|October 21, 2021
Apoptosis reprogramming triggered by splicing inhibitors sensitizes multiple myeloma cells to Venetoclax treatmentDebora Soncini, Claudia Martinuzzi, Pamela Becherini, et al.
Pageof 4